On April 13, 2020 Sutro Biopharma, Inc. (NASDAQ: STRO), reported that the company has been invited to present updated clinical data from its STRO-002 antibody-drug conjugate (ADC) at the upcoming AACR (Free AACR Whitepaper) Virtual Annual Meeting 2020 (Press release, Sutro Biopharma, APR 13, 2020, View Source [SID1234556266]). The submitted abstract and a virtual poster presentation, which will consist of further updated data accompanied by a video presentation from Dr. Wendel Naumann of The Levine Cancer Institute, will be available on demand on the AACR (Free AACR Whitepaper) website (aacr.org) on Monday, April 27. Additionally, Sutro will host a conference call and live audio webcast on Monday, April 27 to discuss the STRO-002 clinical data, details of the call will be provided within the next week.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The AACR (Free AACR Whitepaper) presentation will include updated initial dose escalation safety and efficacy data from the company’s ongoing Phase I study of STRO-002 in ovarian and endometrial cancer. STRO-002 is a novel ADC targeting the clinically validated folate receptor-α (FolRα), an antigen known to be overexpressed in ovarian cancer. Sutro discovered and manufactures STRO-002 using its proprietary XpressCF+ cell-free protein synthesis technology.

Poster Presentation Details:

STRO-002-GM1, a First in Human, Phase 1 Study of STRO-002, an anti-Folate Receptor-alpha (FRα) Antibody Drug Conjugate (ADC), in Patients with Advanced Platinum-Resistant/Refractory Epithelial Ovarian Cancer (OC), including Fallopian Tube or Primary Peritoneal Cancers

Date: Monday, April 27, 2020

Abstract Number: 9807

The abstract title was published today on the AACR (Free AACR Whitepaper) website. The submitted abstract and the virtual poster presentation will be also accessible through the Clinical/Scientific Presentation and Publication Highlights page of the News section of the company’s website at www.sutrobio.com on the day of the poster presentation.